Free Trial

Marechale Capital (MAC) Competitors

Marechale Capital logo
GBX 1.80 +0.05 (+2.86%)
As of 04:07 AM Eastern

MAC vs. EXR, MRS, AMP, EARN, ORM, OSI, NNN, PEL, RENE, and PPHP

Should you be buying Marechale Capital stock or one of its competitors? The main competitors of Marechale Capital include ENGAGE XR (EXR), Management Resource Solutions (MRS), Amphion Innovations (AMP), EARNZ (EARN), Ormonde Mining (ORM), Osirium Technologies (OSI), nanosynth group (NNN), Paragon Entertainment (PEL), ReNeuron Group (RENE), and Papillon (PPHP). These companies are all part of the "trading" industry.

Marechale Capital vs. Its Competitors

ENGAGE XR (LON:EXR) and Marechale Capital (LON:MAC) are both small-cap trading companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, ENGAGE XR's average media sentiment score of 0.00 beat Marechale Capital's score of -0.18 indicating that ENGAGE XR is being referred to more favorably in the media.

Company Overall Sentiment
ENGAGE XR Neutral
Marechale Capital Neutral

ENGAGE XR has a beta of -0.56, meaning that its share price is 156% less volatile than the S&P 500. Comparatively, Marechale Capital has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

Marechale Capital has a net margin of -27.36% compared to ENGAGE XR's net margin of -115.52%. Marechale Capital's return on equity of -5.47% beat ENGAGE XR's return on equity.

Company Net Margins Return on Equity Return on Assets
ENGAGE XR-115.52% -21.89% -26.98%
Marechale Capital -27.36%-5.47%-5.40%

36.6% of ENGAGE XR shares are owned by institutional investors. 35.0% of ENGAGE XR shares are owned by company insiders. Comparatively, 56.0% of Marechale Capital shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Marechale Capital has lower revenue, but higher earnings than ENGAGE XR. Marechale Capital is trading at a lower price-to-earnings ratio than ENGAGE XR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENGAGE XR£2.06M3.55-£2.38M-£0.28-3.91
Marechale Capital£662.58K2.85-£181.28K-£0.17-10.32

Summary

Marechale Capital beats ENGAGE XR on 7 of the 12 factors compared between the two stocks.

Get Marechale Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for MAC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MAC vs. The Competition

MetricMarechale CapitalCapital Markets IndustryFinancial SectorLON Exchange
Market Cap£1.89M£951.78M£6.46B£3.22B
Dividend Yield2.88%3.88%4.16%5.01%
P/E Ratio-10.3250.2730.53708.31
Price / Sales2.85158.841,766.2915,074.92
Price / Cash0.5711.88127.5027.93
Price / Book0.573.705.276.89
Net Income-£181.28K£130.65M£1.23B£5.89B
7 Day Performance4.05%1.39%0.03%0.23%
1 Month Performance-18.18%2.18%2.57%50.01%
1 Year Performance38.46%31.85%24.33%150.47%

Marechale Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAC
Marechale Capital
N/AGBX 1.80
+2.9%
N/AN/A£1.89M£662.58K-10.32650Gap Down
EXR
ENGAGE XR
N/AGBX 1.08
flat
N/A+25.3%£7.20M£2.06M-3.844,780Gap Down
MRS
Management Resource Solutions
N/AN/AN/AN/A£5.70MN/A1.3412,200
AMP
Amphion Innovations
N/AGBX 2.56
+0.3%
N/A+1,641.3%£5.37M£6.49B0.0313,500
EARN
EARNZ
N/AGBX 4.26
+0.1%
N/A-35.8%£4.35M£974.54K-0.9611
ORM
Ormonde Mining
N/AN/AN/AN/A£3.54MN/A-2.506
OSI
Osirium Technologies
N/AN/AN/AN/A£2.70M£2.09M-110.003
NNN
nanosynth group
N/AN/AN/AN/A£2.58M£85.65K-1.1280High Trading Volume
PEL
Paragon Entertainment
N/AN/AN/AN/A£2.37M£10.84M-0.9682,400Gap Down
RENE
ReNeuron Group
N/AN/AN/AN/A£1.93M£783K-37.502Gap Down
PPHP
Papillon
N/AN/AN/AN/A£1.75MN/A0.003Gap Up

Related Companies and Tools


This page (LON:MAC) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners